Hitting the bullseye with psoriasis treatments

More treatment options for psoriasis are available than ever before; however, research shows that the disease is still a significant problem for many. Surveys conducted by the National Psoriasis Foundation among people with psoriasis reveal that most living with the disease are either dissatisfied with their treatment or not using treatments appropriate to their level of disease severity.

Now NPF’s Medical Board—a group of more than 30 of the leading experts in psoriatic disease diagnosis, treatment and research—has set specific treatment goals that will make achieving clear or almost clear skin the new standard of care for psoriasis. This treatment strategy, known as “Treat to Target,” was published online in the Journal of the American Academy of Dermatology in November 2016.

“Treat to Target” is a disease treatment strategy whereby an individual and their health care provider set specific targets or goals for improved health outcomes. The goals are meant to reduce the severity of plaque psoriasis so it covers 1 percent or less of a person’s body within three months after starting a treatment. Establishing these recommendations aligns with NPF’s mission to drive efforts to cure psoriatic disease and dramatically improve the lives of those affected.

Click on the links below to learn more about the recommendations, how they were developed, and what people with psoriasis and their providers can do to hit their treatment targets.

For Patients For Providers

 

Thanks to our sponsors

Novartis Lilly Valeant